Financial Personal
Onc.AI Awarded $2 Million National Cancer Institute Grant to Advance AI-based Clinical Decision Support for Metastatic NSCLC
The Direct-to-Phase II SBIR grant will fund prospective validation and expanded development of Onc.AI’s advanced AI-based clinical decision support tool for non-small cell lung cancer. SAN CARLOS, Calif. & WATERLOO, Ontario — Onc.AI, a dig
The Direct-to-Phase II SBIR grant will fund prospective validation and expanded development of Onc.AI’s advanced AI-based clinical decision support tool for non-small cell lung cancer. Read More
